Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
172.1 USD | +0.81% |
|
-0.04% | +11.03% |
Jun. 25 | FDA Again Rejects AbbVie Parkinson's Drug/Pump Combo -- Update | DJ |
Jun. 25 | AbbVie Issues Regulatory Update on New Drug Application for ABBV-951 to Treat Parkinson's Disease | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.03% | 302B | |
+54.48% | 815B | |
+44.25% | 654B | |
-6.30% | 354B | |
+21.19% | 337B | |
+18.45% | 247B | |
+2.09% | 229B | |
+13.03% | 219B | |
+8.80% | 171B | |
-4.86% | 159B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Transcript : AbbVie Inc., Q2 2023 Earnings Call, Jul 27, 2023